The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: Similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators

20Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

The activation of CD4+ T helper cells is strictly dependent on the presentation of antigenic peptides by MHC class II (MHC-II) molecules. MHC-II expression is primarily regulated at the transcriptional level by the AIR-1 gene product CIITA (class II transactivator). Thus, CIITA plays a pivotal role in the triggering of the adaptive immune response against pathogens. Besides this well known function, we recently found that CIITA acts as an endogenous restriction factor against HTLV-1 (human T cell lymphotropic virus type 1) and HTLV-2 oncogenic retroviruses by targeting their viral transactivators Tax-1 and Tax-2, respectively. Here we review our findings on CIITA-mediated inhibition of viral replication and discuss similarities and differences in the molecular mechanisms by which CIITA specifically counteracts the function of Tax-1 and Tax-2 molecules. The dual function of CIITA as a key regulator of adaptive and intrinsic immunity represents a rather unique example of adaptation of host-derived factors against pathogen infections during evolution. © 2013 Forlani, Abdallah, Accolla and Tosi.

Cite

CITATION STYLE

APA

Forlani, G., Abdallah, R., Accolla, R. S., & Tosi, G. (2013). The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: Similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators. Frontiers in Microbiology. Frontiers Research Foundation. https://doi.org/10.3389/fmicb.2013.00234

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free